rs200490093
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_014855.3(AP5Z1):c.313C>T(p.His105Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000269 in 1,588,848 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014855.3 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hereditary spastic paraplegia 48Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AP5Z1 | NM_014855.3 | c.313C>T | p.His105Tyr | missense_variant | Exon 3 of 17 | ENST00000649063.2 | NP_055670.1 | |
| AP5Z1 | NR_157345.1 | n.406C>T | non_coding_transcript_exon_variant | Exon 3 of 17 | ||||
| AP5Z1 | NM_001364858.1 | c.-103+389C>T | intron_variant | Intron 2 of 15 | NP_001351787.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152236Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000465 AC: 113AN: 242932 AF XY: 0.000483 show subpopulations
GnomAD4 exome AF: 0.000258 AC: 371AN: 1436494Hom.: 0 Cov.: 31 AF XY: 0.000265 AC XY: 188AN XY: 708708 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000368 AC: 56AN: 152354Hom.: 1 Cov.: 33 AF XY: 0.000295 AC XY: 22AN XY: 74498 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:4
- -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
- -
Hereditary spastic paraplegia 48 Uncertain:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 105 of the AP5Z1 protein (p.His105Tyr). This variant is present in population databases (rs200490093, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with AP5Z1-related conditions. ClinVar contains an entry for this variant (Variation ID: 360306). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt AP5Z1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Retinal dystrophy Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at